InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Discover the full record of transactions filed by Altarac David, Directeur Médical. Director active across 1 companies, notably Entasis Therapeutics Holdings Inc.. Cumulatively, 6 disclosures have been logged. The latest transaction was disclosed on 18 January 2022 — Attribution. Regulator: SEC (Form 4). All data is free.
Declarations6 total
0125,000 shares0
Common Stock
SEC:0001104659-22-005409·
0125,000 shares0
Common Stock
SEC:0001104659-22-005409:0·
€9,2993,669 shares@ €2.5346100.0% of flow
Common Stock
SEC:0001104659-21-133630·
€9,2993,669 shares@ €2.534650.0% of flow
Common Stock
SEC:0001104659-21-133630:0·
025,000 shares0
Common Stock
SEC:0001104659-21-128056·
025,000 shares0
Common Stock
SEC:0001104659-21-128056:0·
6 of 6 declarations
About Altarac David
David Altarac is the Chief Medical Officer of Entasis Therapeutics Holdings Inc. He oversees the clinical and medical aspects of the company's research and development projects. His medical expertise is essential to ensure the quality and efficacy of the treatments developed.
